Advertisement
Home Blog Page 3668
For patients with type 2 diabetes

Long-Acting Analog Insulin Doesn’t Up AMI Risk in T2DM

0
No significant difference in risk for long-acting analog, other basal insulin therapies
In a practice bulletin published in the September issue of Obstetrics & Gynecology

ACOG: Best Evidence for Rx of Nausea, Vomiting in Pregnancy

0
Vitamin B6 or vitamin B6 plus doxylamine is safe and effective; recommended for first-line tx
There is considerable variation in the unit cost of topical corticosteroids across potencies and by branded generic or generic product

Considerable Variation in Cost of Generic Topical Corticosteroids

0
Variation in cost seen across potencies, class, and by branded generic or generic product
Oral contraceptive exposure is associated with better patient-reported outcomes in early inflammatory arthritis

Oral Contraceptive Use May Moderate Inflammatory Arthritis

0
OC use linked to better Rheumatoid Arthritis Impact of Disease scores over two years
Working long hours is associated with increased risk of stroke

Long Work Hours Linked to Increased Risk of Stroke

0
Association with coronary heart disease is smaller; dose-response association seen for stroke
For some

BRAF V600 Is Targetable in Some Nonmelanoma Cancers

0
Vemurafenib active in NSCLC, Erdheim-Chester disease, Langerhans'-cell histiocytosis
Obesity enhances local myofibroblast content and stiffness-promoting extracellular matrix components in mammary adipose tissue

Obesity May Fuel Breast CA Via Change in Breast Tissue Structure

0
Findings suggest obesity can trigger structural changes in extracellular matrix
Two-thirds of acute abdominal aortic aneurysm events occur in those aged ≥75 years

Two-Thirds of Acute AAA Occur in Those Aged 75 Years and Older

0
Overall, 96.4 percent of events in men aged younger than 75 years occur in ever smokers
Treatment with a dual wavelength non-ablative fractional laser may result in the functional improvement of scar contractures

Non-Ablative Fractional Laser Could Treat Scar Contracture

0
Improvement seen both in appearance and range of motion after treatment
Addyi (flibanserin) has been approved by the U.S. Food and Drug Administration as the first drug to treat generalized hypoactive sexual desire disorder among premenopausal women. The drug is for women who do not have an underlying physical or psychological cause for the disorder

FDA Approves Libido Pill for Women

0
Addyi to treat generalized hypoactive sexual desire disorder among premenopausal women